Hydrocortisone: Clinical Trials

124 trials of Hydrocortisone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 17 terminated, 12 unknown, 9 recruiting. 124 Phase 2, 16 Phase 1, 13 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2124Completed 72, Terminated 17, Unknown 12, Recruiting 9, Active not recruiting 5, Withdrawn 5, Not yet recruiting 4
Phase 116Completed 7, Terminated 5, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 313Completed 7, Unknown 3, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Hydrocortisone: new trials by email Literature Review of Hydrocortisone trials Research Report on Hydrocortisone

Trials (filtered) newest first · largest first

All 124 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Osilodrostat (Isturisa), Placebo, hydrocortisone 10mg - Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Phase 2Not yet recruitingBeckey Trinh442026-11-012026-11-06
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
Yohimbine + Hydrocortisone, Active rTMS, Placebo - Opioid Use Disorder
Phase 2Not yet recruitingWayne State University202026-10-012025-12-30
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Therapeutic Hydrocortisone, Cytarabine, Dexamethasone - Non-hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma
Phase 2RecruitingVanderbilt-Ingram Cancer Center592026-09-252026-10-02
Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."
Revumenib, Fludarabine, Cytarabine (Ara-C) - Leukemia, Myeloid, Acute
Phase 2Not yet recruitingTherapeutic Advances in Childhood Leukemia Consortium242026-08-312026-07-22
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082026-08-282026-07-30
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Tocilizumab, Baricitinib, Anakinra - Sepsis
Phase 2RecruitingAssistance Publique - Hôpitaux de Paris20002026-07-092026-10-20
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Asciminib Adult formulation, Asciminib Pediatric formulation, Dexamethasone - Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Phase 1 / Phase 2RecruitingNovartis Pharmaceuticals502026-07-052026-11-12
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)1532025-06-052026-10-27
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
Biospecimen Collection, Cytarabine, Lumbar Puncture - Hematopoietic and Lymphatic System Neoplasm
Phase 2RecruitingOHSU Knight Cancer Institute262025-06-042026-11-10
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Dexamethasone, Vincristine, Inotuzumab - Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Phase 2RecruitingSt. Jude Children's Research Hospital1282025-01-232026-07-16
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Dexamethasone, Vincristine, Daunorubicin - T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma
Phase 2RecruitingSt. Jude Children's Research Hospital1002024-12-272026-08-10
A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome
Methylprednisolone, Dexamethasone, Hydrocortisone - Acute Respiratory Distress Syndrome
Phase 2 / Phase 3CompletedFayoum University1952024-08-012026-09-01
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Phase 2Active not recruitingChildren's Oncology Group782024-01-082026-08-25
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
Anti-CD123 ADC IMGN632, Bone Marrow Aspiration and Biopsy, Cytarabine - Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia
Phase 1 / Phase 2WithdrawnChildren's Oncology Group2023-08-012023-09-01
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event
Phase 2UnknownMahidol University1602023-07-052024-04-05
Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use
Placebo oral tablet, Yohimbine + Hydrocortisone, sham rTMS - Stress, Opioid-use Disorder
Phase 2WithdrawnWayne State University2023-04-102023-04-13
rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers
yohimbine + hydrocortisone, medial prefrontal cortex rTMS, Placebo oral tablet - Stress, Healthy
Phase 2WithdrawnWayne State University2023-04-102023-04-13
Androgen Reduction in Congenital Adrenal Hyperplasia
Abiraterone acetate, Placebo, Hydrocortisone - Congenital Adrenal Hyperplasia
Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2023-01-012023-02-01
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Tacrolimus ointment, Hydrocortisone 1% cream - Dermatologic Disease
Phase 2CompletedTanta University1002022-11-282026-10-30
Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.
Solu-Cortef - Oral Pyogenic Granuloma
Phase 2 / Phase 3UnknownBeni-Suef University302022-05-012022-09-14

Showing 20 of 124. Sign in to see all of them.

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (23)  ·  Leukemia (14)  ·  Burkitt Lymphoma (13)  ·  Prostatic Neoplasms (11)  ·  Leukemia, Biphenotypic, Acute (7)  ·  Lymphoma (7)  ·  Sepsis (7)  ·  Addison Disease (6)  ·  Adrenal Hyperplasia, Congenital (6)  ·  Lymphoma, Large B-Cell, Diffuse (6)  ·  Shock, Septic (6)  ·  Adrenal Insufficiency (5)  ·  Leukemia, Myeloid, Acute (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Lymphoma, Mantle-Cell (3)

Sponsors

National Cancer Institute (NCI) (10)  ·  Children's Oncology Group (8)  ·  St. Jude Children's Research Hospital (6)  ·  Haukeland University Hospital (5)  ·  Beth Israel Deaconess Medical Center (4)  ·  Dana-Farber Cancer Institute (4)  ·  Stanford University (4)  ·  Wayne State University (3)  ·  Asan Medical Center (2)  ·  Soroka University Medical Center (2)  ·  Therapeutic Advances in Childhood Leukemia Consortium (2)  ·  University of California, San Francisco (2)  ·  University of Texas Southwestern Medical Center (2)  ·  AIDS Malignancy Consortium (1)  ·  Academic and Community Cancer Research United (1)

Countries

United States (77)  ·  Canada (16)  ·  Australia (11)  ·  Puerto Rico (7)  ·  France (5)  ·  Norway (5)  ·  Switzerland (5)  ·  Israel (4)  ·  Egypt (3)  ·  Germany (3)  ·  South Korea (3)  ·  Brazil (2)  ·  Finland (2)  ·  Japan (2)  ·  New Zealand (2)

Top investigators

Michael W Donnino, MD (2)  ·  Sima Jeha, MD (2)  ·  Wen-Kai Weng (2)  ·  Adham Mohamed, PharmD (1)  ·  Adrian Corneliu Iancu, M.D, Ph.D (1)  ·  Allan G Coates, DO (1)  ·  Allen Yeoh, MBBS (1)  ·  Aminah Jatoi (1)  ·  Andrew Wolf, MBBChir MD (1)  ·  Anna G Nilsson, MD, PhD (1)  ·  Ariela Noy, MD (1)  ·  Barb Melosky, MD (1)  ·  Barbara Pro, MD (1)  ·  Barton Kamen, MD (1)

Results publications

PMID 41671463, PMID 35622074, PMID 38767196, PMID 10722036, PMID 1138591, PMID 11502226, PMID 11600602, PMID 12011123, PMID 12454520, PMID 12545007, PMID 12700374, PMID 15042678, PMID 1607900, PMID 16556894, PMID 16570523, PMID 16809737, PMID 17136402, PMID 18353115, PMID 19064966, PMID 19638218, PMID 19648788, PMID 20332511, PMID 20646908, PMID 20871859, PMID 21427372, PMID 22210879, PMID 22488662, PMID 22563089, PMID 227054, PMID 22777514, PMID 22835045, PMID 23140612, PMID 23450051, PMID 23525934, PMID 23672956, PMID 24484547, PMID 24838355, PMID 25667107, PMID 25957391, PMID 26218852, PMID 26376074, PMID 26527777, PMID 26573073, PMID 26771781, PMID 26903338, PMID 27038920, PMID 27162802, PMID 27429037, PMID 27680873, PMID 27695824

NIH funding

U10CA180886 (7), U10CA098543 (6), N01CM00071 (2), P30CA014599 (2), 2009 (1), 2025 (1), K23NS048152 (1), N01CM00038 (1), N01CM00099 (1), N01CM62201 (1), N01CM62204 (1), N01CM62209 (1), P01CA049605 (1), P30CA006516 (1), P30CA006973 (1)